Smoked cannabis effective in pain and hyperanalgesia modulation in HIV-SN patients
Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trialNeurology. 2007;(7):515-21.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
55 patients with HIV-associated sensory neuropathy (HIV-SN) were randomly assigned to receive either one 0.9g cigarette (3.56% delta-9-tetrahydrocannabinol) per day for 5 days, or its respective placebo with the identical schedule. Patients were assessed on pain on Visual Analogue Scale (VAS), hyperanalgesia, pain to heat stimulation, and incidence and severity of adverse events daily for 12 days....
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.Continue